Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population

Heart

Volumn 86, Issue 1, 2001, Pages 21-26

  McDonagh, T A ^a   Cunningham, A D ^a   Morrison, C E ^b   McMurray, J J V ^a   Ford, I ^a   Morton, J J ^a   Dargie, H J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

Author keywords

Epidemiology; Left ventricular dysfunction; Natriuretic peptides

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; URBAN POPULATION;

EID: 0034756487     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.86.1.21     Document Type: Article

References (26)

1. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population
2. The natural history of congestive heart failure: The Framingham study
3. Survival after the onset of congestive heart failure in Framingham heart study subjects
4. The effect of treatment on survival in congestive heart failure
5. Prevalence and mortality rate of congestive heart failure in the United States
6. The incidence and prevalence of congestive heart failure in Rochester, Minnesota
7. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
8. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
9. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial
10. Congestive heart failure in the community
11. Biochemical detection of left ventricular systolic dysfunction
12. N-Terminal proatrial natriuretic factor: An independent predictor of long term prognosis after myocardial infarction
13. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide
14. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure
15. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction
16. N-terminal (1-25) atrial natriuretic factor in human congestive heart failure: A marker for endogenous secretion
17. The effect of intravenous saline loading on plasma levels of brain natriuretic peptide in man
18. Risk factors for heart failure in the general population. The study of the men born in 1913
19. Prognostic value of plasma endothelin-1 in patients with chronic heart failure
20. Brain natriuretic peptide predicts mortality in the elderly
21. Associations between atrial natriuretic peptides, echocardiographic findings and mortality in an elderly population sample
22. Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure
23. Brain natriuretic peptide as a cardiac hormone in essential hypertension
24. Natriuretic peptide system in human heart failure
25. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes